Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARP-SE trial: Silk-elastin (P47K-WAS-MR) for meniscus repair
jRCT2062220056Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of P47K-WAS-MR in Meniscus Tear (MT), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Safety: Adverse events and device failures. Started Aug 2022; status: active, not recruiting.
02
Drugs
P47K-WAS-MR
03
Conditions
Meniscus Tear (MT)
Beyond the preview
Go deeper on jRCT2062220056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2062220056.